WEST PHARMACEUTICAL SERVICES, INC. Net Income (Loss) Available to Common Stockholders, Diluted
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Net Income (Loss) Available to Common Stockholders, Diluted of $127.10 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-25.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2015-02-25
- WEST PHARMACEUTICAL SERVICES, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2013-12-31 was $23.60M, a 11.32% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2013-09-30 was $26.80M, a 81.08% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2013-06-30 was $30.20M, a 84.15% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2013-03-31 was $31.70M, a 4.62% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. net income (loss) available to common stockholders, diluted for fiscal 2014 was $127.10M, a 13.18% increase from fiscal 2013.
- WEST PHARMACEUTICAL SERVICES, INC. net income (loss) available to common stockholders, diluted for fiscal 2013 was $112.30M, a 35.79% increase from fiscal 2012.
- WEST PHARMACEUTICAL SERVICES, INC. net income (loss) available to common stockholders, diluted for fiscal 2012 was $82.70M, a 3.63% increase from fiscal 2011.
- WEST PHARMACEUTICAL SERVICES, INC. net income (loss) available to common stockholders, diluted for fiscal 2011 was $79.80M, a 14.66% increase from fiscal 2010.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2014-12-31 | $127.10M 10-K · filed 2015-02-25 | |||
| 2013-12-31 | $23.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $50.40M derived: sum of 2 quarters · filed 2015-02-25 | $80.60M derived: sum of 3 quarters · filed 2015-02-25 | $112.30M 10-K · filed 2015-02-25 |
| 2013-09-30 | $26.80M 10-Q · filed 2013-11-04 | $57.00M derived: sum of 2 quarters · filed 2013-11-04 | $88.70M 10-Q · filed 2013-11-04 | $109.90M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-06-30 | $30.20M 10-Q · filed 2013-08-05 | $61.90M 10-Q · filed 2013-08-05 | $83.10M derived: sum of 3 quarters · filed 2015-02-25 | $97.90M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-03-31 | $31.70M 10-Q · filed 2013-05-06 | $52.90M derived: sum of 2 quarters · filed 2015-02-25 | $67.70M derived: sum of 3 quarters · filed 2015-02-25 | $84.10M derived: sum of 4 quarters · filed 2015-02-25 |
| 2012-12-31 | $21.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $36.00M derived: sum of 2 quarters · filed 2015-02-25 | $52.40M derived: sum of 3 quarters · filed 2015-02-25 | $82.70M 10-K · filed 2015-02-25 |
| 2012-09-30 | $14.80M 10-Q · filed 2013-11-04 | $31.20M derived: sum of 2 quarters · filed 2013-11-04 | $61.50M 10-Q · filed 2013-11-04 | $81.40M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $16.40M 10-Q · filed 2013-08-05 | $46.70M 10-Q · filed 2013-08-05 | $66.60M derived: sum of 3 quarters · filed 2014-02-27 | $84.60M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $30.30M 10-Q · filed 2013-05-06 | $50.20M derived: sum of 2 quarters · filed 2014-02-27 | $68.20M derived: sum of 3 quarters · filed 2014-02-27 | $89.40M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $19.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $37.90M derived: sum of 2 quarters · filed 2014-02-27 | $59.10M derived: sum of 3 quarters · filed 2014-02-27 | $79.80M 10-K · filed 2014-02-27 |
| 2011-09-30 | $18.00M 10-Q · filed 2012-11-05 | $39.20M derived: sum of 2 quarters · filed 2012-11-05 | $59.90M 10-Q · filed 2012-11-05 | $67.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $21.20M 10-Q · filed 2012-08-06 | $41.80M 10-Q · filed 2012-08-06 | $49.00M derived: sum of 3 quarters · filed 2013-02-27 | $67.90M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $20.70M 10-Q · filed 2012-05-04 | $27.80M derived: sum of 2 quarters · filed 2013-02-27 | $46.70M derived: sum of 3 quarters · filed 2013-02-27 | $69.50M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $26.00M derived: sum of 2 quarters · filed 2013-02-27 | $48.80M derived: sum of 3 quarters · filed 2013-02-27 | $69.60M 10-K · filed 2013-02-27 |
| 2010-09-30 | $18.90M 10-Q · filed 2011-11-07 | $41.70M derived: sum of 2 quarters · filed 2011-11-07 | $62.50M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $22.80M 10-Q/A · filed 2011-08-08 | $43.70M 10-Q/A · filed 2011-08-08 | ||
| 2009-12-31 | $76.90M 10-K/A · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |